Hester Biosciences Ltd.

View in App
1660.70 -23.80 ▼-1.4%

25 April 2024, 04:05:35 PM
Volume: 11,634

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hester.in
Market Cap 1,414.27 Cr.
Enterprise Value(EV) 1,681.97 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 21.71 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 76.57 Trailing Twelve Months Ending 2023-12
Industry PE 41.30 Trailing Twelve Months Ending 2023-12
Book Value / Share 334.71 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.97 Calculated using Price: 1,662.50
Dividend Yield 0.48 Period Ending 2023-03
No. of Shares Subscribed 0.85 Cr. 8,506,865 Shares
FaceValue 10
About Hester Biosciences Ltd.
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

Hester Biosciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Hester Biosciences Ltd. Performance

View details >>
1 Day
-1.41%
1 Week
+2.96%
1 Month
+18.80%
3 Month
+9.87%
6 Month
+0.46%
1 Year
-7.45%
2 Year
-36.20%
5 Year
+11.63%
10 Year

Hester Biosciences Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 16.73 20.56 20.38 17.57 25.59 16.38 16.16 16.17 10.39
Return on Capital Employed (%) 17.26 18.98 19.75 20.2 26.64 16.53 17.33 14.12 9.6
Return on Assets (%) 8.84 11.08 11.43 10.1 14.97 9.04 8.7 8.11 4.55

Hester Biosciences Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 85 102 122 141 177 201 228 260 280 282
Non Curr. Liab. 38 41 48 44 70 97 114 198 233 260
Curr. Liab. 35 38 38 55 49 83 61 97 149 132
Minority Int. 3 5 5 4 4 5 8 7 9 10
Equity & Liab. 160 186 213 244 299 387 411 562 670 683
Non Curr. Assets 100 112 133 146 158 227 250 367 442 445
Curr. Assets 60 74 80 98 142 159 162 195 228 238
Misc. Exp. not W/O
Total Assets 160 186 213 244 299 387 411 562 670 683

Hester Biosciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 90 101 123 136 178 183 214 235 266 293
Other Income 0 1 0 3 7 6 5 14 15 10
Total Income 90 102 124 138 185 190 219 249 281 302
Total Expenditure -65 -68 -82 -89 -110 -128 -146 -175 -216 -243
PBIDT 26 34 41 50 75 62 73 74 66 59
Interest -5 -4 -4 -4 -7 -7 -7 -4 -9 -14
Depreciation -6 -6 -7 -10 -12 -13 -13 -17 -21 -19
Taxation -5 -6 -8 -13 -16 -10 -15 -14 -12 -10
Exceptional Items 3 -3
PAT 13 19 23 23 41 31 35 39 28 16
Minority Interest 0 0 1 3 1 -2 0 0 -1 -2
Share Associate 4
Other Related Items
Consolidated Net Profit 14 19 24 26 42 29 34 39 27 18
Adjusted EPS 16 23 28 30 49 34 40 46 31 22

Hester Biosciences Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 9 20 19 35 38 47 37 58 9 24
Cash Fr. Inv. -15 -21 -13 -30 -26 -22 -74 -38 -117 -77
Cash Fr. Finan. 7 7 -7 2 -11 3 19 -18 112 42
Net Change 2 5 -1 6 1 28 -19 1 4 -12
Cash & Cash Eqvt 4 6 5 11 12 41 24 21 25 13

Hester Biosciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73 53.73
Public 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27 46.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Hester Biosciences Ltd. Announcements

View details >>
Tue, 16 Apr 2024
Disclosure under SEBI Takeover Regulations
Hester Biosciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Mon, 08 Apr 2024
Updates
Hester Biosciences Limited has informed the Exchange regarding 'Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018'.
Thu, 28 Mar 2024
Trading Window-XBRL
HESTER BIOSCIENCES LIMITED has informed the Exchange about Closure of Trading Window

Hester Biosciences Ltd. Technical Scans

View details >>
Wed, 24 Apr 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Hester Biosciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,520.15 +2.3%
Cipla Ltd. 112,292.49 1,406.20 +0.6%
Divi's Laboratories Ltd. 101,276.26 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,218.75 +4.5%
Mankind Pharma Ltd. 95,586.41 2,398.55 +0.0%
Zydus Lifesciences Ltd. 93,730.70 951.25 +1.9%
Torrent Pharmaceuticals Ltd. 90,650.92 2,694.30 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.28 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,694.30 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.34 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,694.30 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,694.30 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,694.30 +0.3%

Hester Biosciences Ltd. FAQ's

What is Hester Biosciences share price?
Can I buy Hester Biosciences shares now?
What is the Dividend Yield of Hester Biosciences?
What is the Market Cap of Hester Biosciences?
What are the key metrics to analyse Hester Biosciences?
What is the 52 Week High and Low of Hester Biosciences?
What is the trend of Hester Biosciences share price?